1 recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
Follow Large Granular Lymphocytic Leukemia: new trials by email Literature Review of Large Granular Lymphocytic Leukemia trials Research Report on Large Granular Lymphocytic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas JAK1 Inhibitor - Lymphoma, T-Cell, NK-LGL Leukemia | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 48 | 2024-12-25 | 2025-11-18 |
| Effect of Cyclosporine Therapy on Gene Expression in Patients With Large Granular Lymphocyte Leukemia Cyclosporine, Gene expression analysis, Microarray analysis - Large Granular Lymphocytic Leukemia, LGL Leukemia | Phase 2 | Terminated | National Cancer Institute (NCI) | 5 | 2006-06-01 | 2015-07-21 |
Leukemia, Large Granular Lymphocytic (2) · Leukemia (1) · Lymphoma, T-Cell (1) · Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia, Lymphoid (2) · Leukemia, T-Cell (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Leukemia (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1)
Cyclosporine (1) · Gene Expression Profiling (1) · Microarray Analysis (1)
Institute of Hematology & Blood Diseases Hospital, China (1) · National Cancer Institute (NCI) (1)
China (1) · United States (1)